Shengtai Pharmaceutical is China's largest manufacturer of intravenous (IV) dextrose solution with a 40% market share.
The company is 1 of only 3 that are licensed to produce IV dextrose monohydrate in China.
New Glucose Manufacturing Facilities expanding production capacity by 100% by end of 2009.
In 2008, SGTI completed the construction of a new glucose manufacturing facility to boost to production capacity from 60,000 tons to 120,000 tons. This expansion is scheduled for "full scale production by calandar year end 2009", according to page 15 of their presentation.
Investor Presentation (Feb. 2009)
Dutton Research Report (Dec. 2008)
Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference (April 29, 2009)
Recent Industry Developmens Reaffirm Positive Glucose Industry Outlook (March 12, 2009)
19M shares issues/outstanding 11M float
SEC Filings (click here)